Copyright Reports & Markets. All rights reserved.

Global Circulating Biomarker Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Circulating Biomarker Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Circulating Biomarker Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Circulating Biomarker Market Size Growth Rate by Type
    • 1.4.2 Circulating DNA
    • 1.4.3 Circulating Tumor Cells
    • 1.4.4 Other
  • 1.5 Market by Application
    • 1.5.1 Global Circulating Biomarker Market Size Growth Rate by Application
    • 1.5.2 Hospital
    • 1.5.3 Medical Research Center
    • 1.5.4 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Circulating Biomarker Market Size, Estimates and Forecasts
    • 2.1.1 Global Circulating Biomarker Revenue 2015-2026
    • 2.1.2 Global Circulating Biomarker Sales 2015-2026
  • 2.2 Global Circulating Biomarker, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Circulating Biomarker Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Circulating Biomarker Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Circulating Biomarker Competitor Landscape by Players

  • 3.1 Circulating Biomarker Sales by Manufacturers
    • 3.1.1 Circulating Biomarker Sales by Manufacturers (2015-2020)
    • 3.1.2 Circulating Biomarker Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Circulating Biomarker Revenue by Manufacturers
    • 3.2.1 Circulating Biomarker Revenue by Manufacturers (2015-2020)
    • 3.2.2 Circulating Biomarker Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Circulating Biomarker Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Circulating Biomarker Revenue in 2019
    • 3.2.5 Global Circulating Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Circulating Biomarker Price by Manufacturers
  • 3.4 Circulating Biomarker Manufacturing Base Distribution, Product Types
    • 3.4.1 Circulating Biomarker Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Circulating Biomarker Product Type
    • 3.4.3 Date of International Manufacturers Enter into Circulating Biomarker Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Circulating Biomarker Market Size by Type (2015-2020)
    • 4.1.1 Global Circulating Biomarker Sales by Type (2015-2020)
    • 4.1.2 Global Circulating Biomarker Revenue by Type (2015-2020)
    • 4.1.3 Circulating Biomarker Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Circulating Biomarker Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Circulating Biomarker Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Circulating Biomarker Revenue Forecast by Type (2021-2026)
    • 4.2.3 Circulating Biomarker Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Circulating Biomarker Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Circulating Biomarker Market Size by Application (2015-2020)
    • 5.1.1 Global Circulating Biomarker Sales by Application (2015-2020)
    • 5.1.2 Global Circulating Biomarker Revenue by Application (2015-2020)
    • 5.1.3 Circulating Biomarker Price by Application (2015-2020)
  • 5.2 Circulating Biomarker Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Circulating Biomarker Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Circulating Biomarker Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Circulating Biomarker Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Circulating Biomarker by Country
    • 6.1.1 North America Circulating Biomarker Sales by Country
    • 6.1.2 North America Circulating Biomarker Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Circulating Biomarker Market Facts & Figures by Type
  • 6.3 North America Circulating Biomarker Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Circulating Biomarker by Country
    • 7.1.1 Europe Circulating Biomarker Sales by Country
    • 7.1.2 Europe Circulating Biomarker Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Circulating Biomarker Market Facts & Figures by Type
  • 7.3 Europe Circulating Biomarker Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Circulating Biomarker by Region
    • 8.1.1 Asia Pacific Circulating Biomarker Sales by Region
    • 8.1.2 Asia Pacific Circulating Biomarker Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Circulating Biomarker Market Facts & Figures by Type
  • 8.3 Asia Pacific Circulating Biomarker Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Circulating Biomarker by Country
    • 9.1.1 Latin America Circulating Biomarker Sales by Country
    • 9.1.2 Latin America Circulating Biomarker Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Circulating Biomarker Market Facts & Figures by Type
  • 9.3 Central & South America Circulating Biomarker Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Circulating Biomarker by Country
    • 10.1.1 Middle East and Africa Circulating Biomarker Sales by Country
    • 10.1.2 Middle East and Africa Circulating Biomarker Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Circulating Biomarker Market Facts & Figures by Type
  • 10.3 Middle East and Africa Circulating Biomarker Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Abbott Laboratories
    • 11.1.1 Abbott Laboratories Corporation Information
    • 11.1.2 Abbott Laboratories Description and Business Overview
    • 11.1.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Abbott Laboratories Circulating Biomarker Products Offered
    • 11.1.5 Abbott Laboratories Related Developments
  • 11.2 Becton, Dickinson and Company
    • 11.2.1 Becton, Dickinson and Company Corporation Information
    • 11.2.2 Becton, Dickinson and Company Description and Business Overview
    • 11.2.3 Becton, Dickinson and Company Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Becton, Dickinson and Company Circulating Biomarker Products Offered
    • 11.2.5 Becton, Dickinson and Company Related Developments
  • 11.3 GE Healthcare
    • 11.3.1 GE Healthcare Corporation Information
    • 11.3.2 GE Healthcare Description and Business Overview
    • 11.3.3 GE Healthcare Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 GE Healthcare Circulating Biomarker Products Offered
    • 11.3.5 GE Healthcare Related Developments
  • 11.4 Epigenomics AG
    • 11.4.1 Epigenomics AG Corporation Information
    • 11.4.2 Epigenomics AG Description and Business Overview
    • 11.4.3 Epigenomics AG Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Epigenomics AG Circulating Biomarker Products Offered
    • 11.4.5 Epigenomics AG Related Developments
  • 11.5 Agilent Technologies
    • 11.5.1 Agilent Technologies Corporation Information
    • 11.5.2 Agilent Technologies Description and Business Overview
    • 11.5.3 Agilent Technologies Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Agilent Technologies Circulating Biomarker Products Offered
    • 11.5.5 Agilent Technologies Related Developments
  • 11.6 Biocept
    • 11.6.1 Biocept Corporation Information
    • 11.6.2 Biocept Description and Business Overview
    • 11.6.3 Biocept Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Biocept Circulating Biomarker Products Offered
    • 11.6.5 Biocept Related Developments
  • 11.7 Affymetrix
    • 11.7.1 Affymetrix Corporation Information
    • 11.7.2 Affymetrix Description and Business Overview
    • 11.7.3 Affymetrix Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Affymetrix Circulating Biomarker Products Offered
    • 11.7.5 Affymetrix Related Developments
  • 11.8 Fluxion Biosciences
    • 11.8.1 Fluxion Biosciences Corporation Information
    • 11.8.2 Fluxion Biosciences Description and Business Overview
    • 11.8.3 Fluxion Biosciences Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Fluxion Biosciences Circulating Biomarker Products Offered
    • 11.8.5 Fluxion Biosciences Related Developments
  • 11.1 Abbott Laboratories
    • 11.1.1 Abbott Laboratories Corporation Information
    • 11.1.2 Abbott Laboratories Description and Business Overview
    • 11.1.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Abbott Laboratories Circulating Biomarker Products Offered
    • 11.1.5 Abbott Laboratories Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Circulating Biomarker Market Estimates and Projections by Region
    • 12.1.1 Global Circulating Biomarker Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Circulating Biomarker Revenue Forecast by Regions 2021-2026
  • 12.2 North America Circulating Biomarker Market Size Forecast (2021-2026)
    • 12.2.1 North America: Circulating Biomarker Sales Forecast (2021-2026)
    • 12.2.2 North America: Circulating Biomarker Revenue Forecast (2021-2026)
    • 12.2.3 North America: Circulating Biomarker Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Circulating Biomarker Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Circulating Biomarker Sales Forecast (2021-2026)
    • 12.3.2 Europe: Circulating Biomarker Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Circulating Biomarker Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Circulating Biomarker Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Circulating Biomarker Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Circulating Biomarker Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Circulating Biomarker Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Circulating Biomarker Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Circulating Biomarker Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Circulating Biomarker Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Circulating Biomarker Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Circulating Biomarker Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Circulating Biomarker Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Circulating Biomarker Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Circulating Biomarker Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Circulating Biomarker Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Circulating Biomarker Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Circulating Biomarker market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Circulating Biomarker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Circulating Biomarker market is segmented into
    Circulating DNA
    Circulating Tumor Cells
    Other

    Segment by Application, the Circulating Biomarker market is segmented into
    Hospital
    Medical Research Center
    Others

    Regional and Country-level Analysis
    The Circulating Biomarker market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Circulating Biomarker market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Circulating Biomarker Market Share Analysis
    Circulating Biomarker market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Circulating Biomarker business, the date to enter into the Circulating Biomarker market, Circulating Biomarker product introduction, recent developments, etc.

    The major vendors covered:
    Abbott Laboratories
    Becton, Dickinson and Company
    GE Healthcare
    Epigenomics AG
    Agilent Technologies
    Biocept
    Affymetrix
    Fluxion Biosciences

    Buy now